abstract |
The present invention relates to: a benzoindazolone compound, or a pharmaceutically acceptable salt, hydrate, solvate, enantiomer, diastereomer, tautomer, or prodrug thereof; and an intermediate thereof. A compound according to the present invention is used as a substrate for NQO1 to facilitate a redox reaction of NQO1, and thus is expected to be developable as a medicine for preventing or treating inflammatory diseases. |